Coagulation Parameters During Pregnancy in Amniotic Fluid
NCT00458666 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 170
Last updated 2007-04-11
Summary
Amniotic fluid embolism is a rare devastating thromboembolic event, which is probably caused by the entrance of amniotic fluid (AF) to the maternal circulation. While AF contains coagulation activators, their role during pregnancy has not been elucidated. The current study aimed to evaluate coagulation parameters in AF during human pregnancy.
Conditions
- Pregnancy
Sponsors & Collaborators
-
Rambam Health Care Campus
lead OTHER
Principal Investigators
-
Benjamin Brenner, M.D · Rambam Health Care Campus
-
Arie Drugan, M.D · Rambam Health Care Campus
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-06-30
Countries
- Israel
Study Locations
More Related Trials
-
A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities
NCT00490607 ·Status: UNKNOWN
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
NCT02554604 ·Status: COMPLETED
-
EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies
NCT02407730 ·Status: COMPLETED
-
Amniotic Biomarkers for the Prediction of Postpartum Renal Function.
NCT02675686 ·Status: COMPLETED
-
Identification of Early Predictors of Fetomaternal Hemorrhage
NCT01232387 ·Status: COMPLETED
-
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
NCT02784886 ·Status: UNKNOWN
-
Presence of Nanoparticles in the Amniotic Fluid
NCT02720887 ·Status: COMPLETED
-
Progesterone Levels and Pregnancy Results
NCT04400149 ·Status: UNKNOWN
-
The Role of Cytokines in Apparently Normal Pregnancies
NCT01098214 ·Status: WITHDRAWN
-
Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)
NCT04861103 ·Status: RECRUITING ·Phase: PHASE4
-
Pre-Eclampsia Prediction By Doppler Screening Of Uterine Arteries And Angiogenic Factors In Second Trimester Of Pregnancy
NCT00725660 ·Status: UNKNOWN
-
Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR
NCT00634855 ·Status: TERMINATED
-
Blood Loss and Preeclampsia
NCT04777097 ·Status: RECRUITING
-
The Effect of Single Umbilical Artery Caused by Umbilical Artery Embolism on Pregnancy Outcome
NCT05327036 ·Status: UNKNOWN
-
Evaluation of a Patient Blood Management Protocol Impact on the Transfusion Rate in Delivery Hemorrhage
NCT06916832 ·Status: COMPLETED
-
Markers of Oxidative Stress in a Early Week Miscarriage: Ischemia of Modified Albumin
NCT01988740 ·Status: UNKNOWN
-
Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models
NCT02709174 ·Status: COMPLETED
-
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 ·Status: TERMINATED
-
Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?
NCT04274803 ·Status: WITHDRAWN ·Phase: PHASE4
-
Can Non-invasive Sampling Determine the Inflammatory Status of the Intra-uterine Environment?
NCT01090583 ·Status: COMPLETED
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Use of Platelet Indices for Prediction of Recurrent Miscarriage
NCT03710226 ·Status: COMPLETED
-
Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths
NCT03601338 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 ·Status: RECRUITING